Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

TheraBulb® Introduces Industry First 300 Watt Near Infrared Incandescent Bulb

TheraBulb® Introduces Industry First 300 Watt Near Infrared Incandescent Bulb, the Most Powerful Near-Infrared Light Therapy Bulb Available to Consumers


News provided by

TheraBulb

Feb 18, 2020, 14:00 ET

Share this article

Share toX

Share this article

Share toX

TheraBulb® Infrared Bulbs Offer Lab-Verified Wavelength Output
TheraBulb® Infrared Bulbs Offer Lab-Verified Wavelength Output
Youtube
Youtube

LEESBURG, Va., Feb. 18, 2020 /PRNewswire-PRWeb/ -- TheraBulb® is setting the standard once again with its newest product release: a 300W incandescent bulb that outperforms the competition in near infrared and red light output as well as durability. Powerful and durable, the Near Infrared Bulb - 300 Watt has earned the same safety and purity marks that have made consumers trust the TheraBulb® brand.

The TheraBulb® 300W is a game-changer for consumers using 150W and 250W infrared bulbs. Rather than needing to purchase a second bulb when more coverage or deeper tissue penetration is needed, now they can get that same output from a single bulb. When compared with the 150W bulb, TheraBulb® is offering twice the power at the same price! For those who want more infrared and red light than 250 watt bulbs the TheraBulb® 300W delivers that extra boost. Best of all, the 300W bulb is still compatible with clamp lamps available on Amazon and hardware stores.

An impressive 75% of the TheraBulb® 300W total output registered in the infrared range during lab tests, nearly double the percentage of previous TheraBulb® designs. The bulbs peak output, at 700nm, made up nearly a quarter of the total energy output.

Post this

Is Bigger Always Better?

In the case of infrared light therapy, the answer is often "yes". Studies show that the results of such therapy are often dependent on how deeply the light can penetrate into the treatment area.1,2 As bulbs are moved closer to the skin to gain better penetration, their coverage area becomes smaller, like walking toward a wall with a flashlight in your hand.

In such cases, the user is forced to compromise or purchase additional bulbs and lamps. The new TheraBulb® Near Infrared-Bulb - 300 Watt helps to resolve such issues by providing more power output in a single, affordable unit with a tungsten filament designed specifically to maximize near infrared and red light emissions and 20% thicker glass to resist breakage An impressive 75% of the TheraBulb® 300W total output registered in the infrared range during lab tests, nearly double the percentage of previous TheraBulb® designs. The bulbs peak output, at 700nm, made up nearly a quarter of the total energy output. The bulb's red light scores were equally robust, with the 300W version delivering 1.3 times the red light concentration of competing products.

Why Infrared Light Therapy?

Physicians, researchers, and end consumers are using infrared therapy to treat a wide range of symptoms. Numerous studies have been conducted to test the efficacy of near-infrared light in treating joint pain, joint inflammation, muscle pain, spine injuries, nerve pain, and sports injuries.

Many TheraBulb® customers use their products to treat chronic or acute pain, such as non-specific lower back pain or muscle sprains. Others use their TheraBulb® infrared bulbs and lamps to treat arthritis, skin conditions, increase collagen production and promote wound healing, or to help reverse the visible effects of UV skin damage.1

Near-infrared light therapy uses precise wavelengths of light that are delivered to injury sites to speed cellular regeneration and improve the healing process. Researchers have found that infrared light improves the circulation of blood in the body, improving the flow of oxygen and nutrients to the cells, stimulating the regeneration and repair of injured tissues, and reducing pain and inflammation.2,3

To learn more about TheraBulb® products or to make a purchase, please visit: http://www.therabulb.com
About TheraBulb®

TheraBulb® products are designed for in-home use by consumers seeking the benefits of wavelength energy. Our bulbs are manufactured exclusively for TheraBulb® using non-toxic materials, allowing them to bear the CE mark and the RoHS certification. This means they are free of lead, mercury, Teflon, and other substances regulated under the EU's Restriction of Hazardous Substances Directive.

TheraBulb® offers reseller and professional discount programs to medical professionals who wish to use infrared therapy in their practices, as well as to retailers who wish to resell TheraBulb® to their own customer. For more information, email [email protected].

SOURCES:

1. Effects of low-power light therapy on wound healing: LASER x LED http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000400616&lng=en&tlng=en
2. Dr. Masakazu Imamura, MD, et al. Repeated Thermal Therapy Improves Impaired Vascular Endothelial Function in Patients With Coronary Risk Factors. Vol. 38, No. 4, 2001. Journal of American College of Cardiology: pp 1083-1088
3. Infrared therapy for chronic low back pain: A randomized, controlled trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2539004/

SOURCE TheraBulb

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.